Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs intermittent bolus rocuronium for deep neuromuscular block under general anesthesia
KCT0006904Phase 4Recruiting
- Sponsor
- Kosin University Gospel Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rocuronium, sponsored by Kosin University Gospel Hospital. Started Jan 2022; status: recruiting.
02
Drugs
rocuronium
Beyond the preview
Go deeper on KCT0006904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006904.